hotspot -WSS

hotspot

author：focus 2025-09-27 22:49:18 - browse：89

Three Wegovy injection pens in a row — first opinion coverage from STAT — Adobe

Novo Nordisk will test whether its GLP-1 drugs can help people with alcohol-associated liver disease, and, as part of that, will study if the treatments will change the amount of alcohol people drink.

This appears to be the first time the company is getting involved in research to see if the booming class of GLP-1 diabetes and obesity drugs can affect substance consumption, a question that academic researchers have been probing but the pharmaceutical industry has so far avoided.

The nine-month study will try three drugs alone and in combinations against placebo. The primary outcome being tested is change in liver scarring, or fibrosis, and one of the secondary outcomes is changes in alcohol consumption. The news of the study was first reported by Bloomberg.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Plane’s emergency slide plummets from sky, hits Chicago home

WSS

India sets sights on home

States increasingly look to regulate hospital facility fees

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

The leaders of Italy and Poland say European Union should focus on stopping migration

Norman Reedus' Daryl Dixon

New warning issued for rebooking air travel after delays, cancellations

leisure time

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

hotspot

Continuity nursing helped my family in our darkest PICU moments

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

Medicare details structure of new drug price negotiation program

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

Hepatitis C has a cure — but many Americans still lack access to it

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

Duchenne breakthrough therapy leaves behind pioneering families

Search warrant issued in 1996 disappearance of Kristin Smart

In Memoriam: Notable people who died in 2023

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

leisure time

Seattle police shoot person suspected in downtown stabbing

Condition critical? Britain's beloved but battered National Health Service turns 75

Researchers separate signal from noise in heart wearable data

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

focus

hotspot

Wikipedia

focus